Inhaled Nitric Oxide Market 2027 by Application, End User and Geography | The Insight Partners

Inhaled Nitric Oxide Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Application ( Neonatal Respiratory Treatment, COPD, Malaria Treatment, Tuberculosis Treatment, ARDS, Chronic Wound Healing, Others ); End User ( Hospitals, Clinics, Others ) and Geography

Report Code: TIPRE00009274 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Nitric oxide (NO) refers to a colorless gas that was recognized as a key endothelial-derived vasodilator molecule in 1987. Since then, NO is used majorly as a targeted pulmonary vasodilator that improves clinical outcomes for newborn patients with persistent pulmonary hypertension. Moreover, the gas is also used in various therapeutic applications such as ARDS, PPH, and PPHN.

MARKET DYNAMICS

Inhaled nitric oxide market is anticipated to grow in the forecast period owing to growing prevalence of respiratory disorders, rising number of breathing problems in neonates, and FDA encouragement for clinical inhaled nitric oxide. Moreover, technological advancements in inhaled nitric oxide and new product launches by the market players is likely to create opportunities during the forecast period.

MARKET SCOPE

The "Global Inhaled Nitric Oxide Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Inhaled nitric oxide market with detailed market segmentation by application, end user and geography. The global Inhaled nitric oxide market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Inhaled nitric oxide market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Inhaled nitric oxide market is segmented on the basis of application and end user. Based on application, the market is segmented as neonatal respiratory treatment, COPD, malaria treatment, tuberculosis treatment, ARDS, chronic wound healing, and others. Based on end user the market is segmented into hospitals, clinics, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Inhaled nitric oxide market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Inhaled nitric oxide market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Inhaled nitric oxide market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Inhaled nitric oxide market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Inhaled nitric oxide market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Inhaled nitric oxide market are anticipated to lucrative growth opportunities in the future with the rising demand for Inhaled nitric oxide market in the global market. Below mentioned is the list of few companies engaged in the Inhaled nitric oxide market.

The report also includes the profiles of key Inhaled nitric oxide market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Nu-Med Plus, Inc.
- GENOSYS, Inc.
- Praxair, Inc.
- air Liquide S.A.
- Mallinckrodt Pharmaceuticals
- Merck KgaA
- Novoteris, LLC
- Ikiara Canada, Inc.
- GeNO LLC
- Perma Pure LLC

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Inhaled Nitric Oxide Market - By Application
1.3.2 Inhaled Nitric Oxide Market - By End User
1.3.3 Inhaled Nitric Oxide Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INHALED NITRIC OXIDE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INHALED NITRIC OXIDE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. INHALED NITRIC OXIDE MARKET - GLOBAL MARKET ANALYSIS
6.1. INHALED NITRIC OXIDE - GLOBAL MARKET OVERVIEW
6.2. INHALED NITRIC OXIDE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. INHALED NITRIC OXIDE MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. NEONATAL RESPIRATORY TREATMENT
7.3.1. Overview
7.3.2. Neonatal Respiratory Treatment Market Forecast and Analysis
7.4. COPD
7.4.1. Overview
7.4.2. COPD Market Forecast and Analysis
7.5. MALARIA TREATMENT
7.5.1. Overview
7.5.2. Malaria Treatment Market Forecast and Analysis
7.6. TUBERCULOSIS TREATMENT
7.6.1. Overview
7.6.2. Tuberculosis Treatment Market Forecast and Analysis
7.7. ARDS
7.7.1. Overview
7.7.2. ARDS Market Forecast and Analysis
7.8. CHRONIC WOUND HEALING
7.8.1. Overview
7.8.2. Chronic Wound Healing Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis
8. INHALED NITRIC OXIDE MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. INHALED NITRIC OXIDE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Inhaled Nitric Oxide Market Overview
9.1.2 North America Inhaled Nitric Oxide Market Forecasts and Analysis
9.1.3 North America Inhaled Nitric Oxide Market Forecasts and Analysis - By Application
9.1.4 North America Inhaled Nitric Oxide Market Forecasts and Analysis - By End User
9.1.5 North America Inhaled Nitric Oxide Market Forecasts and Analysis - By Countries
9.1.5.1 United States Inhaled Nitric Oxide Market
9.1.5.1.1 United States Inhaled Nitric Oxide Market by Application
9.1.5.1.2 United States Inhaled Nitric Oxide Market by End User
9.1.5.2 Canada Inhaled Nitric Oxide Market
9.1.5.2.1 Canada Inhaled Nitric Oxide Market by Application
9.1.5.2.2 Canada Inhaled Nitric Oxide Market by End User
9.1.5.3 Mexico Inhaled Nitric Oxide Market
9.1.5.3.1 Mexico Inhaled Nitric Oxide Market by Application
9.1.5.3.2 Mexico Inhaled Nitric Oxide Market by End User
9.2. EUROPE
9.2.1 Europe Inhaled Nitric Oxide Market Overview
9.2.2 Europe Inhaled Nitric Oxide Market Forecasts and Analysis
9.2.3 Europe Inhaled Nitric Oxide Market Forecasts and Analysis - By Application
9.2.4 Europe Inhaled Nitric Oxide Market Forecasts and Analysis - By End User
9.2.5 Europe Inhaled Nitric Oxide Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Inhaled Nitric Oxide Market
9.2.5.1.1 Germany Inhaled Nitric Oxide Market by Application
9.2.5.1.2 Germany Inhaled Nitric Oxide Market by End User
9.2.5.2 France Inhaled Nitric Oxide Market
9.2.5.2.1 France Inhaled Nitric Oxide Market by Application
9.2.5.2.2 France Inhaled Nitric Oxide Market by End User
9.2.5.3 Italy Inhaled Nitric Oxide Market
9.2.5.3.1 Italy Inhaled Nitric Oxide Market by Application
9.2.5.3.2 Italy Inhaled Nitric Oxide Market by End User
9.2.5.4 Spain Inhaled Nitric Oxide Market
9.2.5.4.1 Spain Inhaled Nitric Oxide Market by Application
9.2.5.4.2 Spain Inhaled Nitric Oxide Market by End User
9.2.5.5 United Kingdom Inhaled Nitric Oxide Market
9.2.5.5.1 United Kingdom Inhaled Nitric Oxide Market by Application
9.2.5.5.2 United Kingdom Inhaled Nitric Oxide Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Inhaled Nitric Oxide Market Overview
9.3.2 Asia-Pacific Inhaled Nitric Oxide Market Forecasts and Analysis
9.3.3 Asia-Pacific Inhaled Nitric Oxide Market Forecasts and Analysis - By Application
9.3.4 Asia-Pacific Inhaled Nitric Oxide Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Inhaled Nitric Oxide Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Inhaled Nitric Oxide Market
9.3.5.1.1 Australia Inhaled Nitric Oxide Market by Application
9.3.5.1.2 Australia Inhaled Nitric Oxide Market by End User
9.3.5.2 China Inhaled Nitric Oxide Market
9.3.5.2.1 China Inhaled Nitric Oxide Market by Application
9.3.5.2.2 China Inhaled Nitric Oxide Market by End User
9.3.5.3 India Inhaled Nitric Oxide Market
9.3.5.3.1 India Inhaled Nitric Oxide Market by Application
9.3.5.3.2 India Inhaled Nitric Oxide Market by End User
9.3.5.4 Japan Inhaled Nitric Oxide Market
9.3.5.4.1 Japan Inhaled Nitric Oxide Market by Application
9.3.5.4.2 Japan Inhaled Nitric Oxide Market by End User
9.3.5.5 South Korea Inhaled Nitric Oxide Market
9.3.5.5.1 South Korea Inhaled Nitric Oxide Market by Application
9.3.5.5.2 South Korea Inhaled Nitric Oxide Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Inhaled Nitric Oxide Market Overview
9.4.2 Middle East and Africa Inhaled Nitric Oxide Market Forecasts and Analysis
9.4.3 Middle East and Africa Inhaled Nitric Oxide Market Forecasts and Analysis - By Application
9.4.4 Middle East and Africa Inhaled Nitric Oxide Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Inhaled Nitric Oxide Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Inhaled Nitric Oxide Market
9.4.5.1.1 South Africa Inhaled Nitric Oxide Market by Application
9.4.5.1.2 South Africa Inhaled Nitric Oxide Market by End User
9.4.5.2 Saudi Arabia Inhaled Nitric Oxide Market
9.4.5.2.1 Saudi Arabia Inhaled Nitric Oxide Market by Application
9.4.5.2.2 Saudi Arabia Inhaled Nitric Oxide Market by End User
9.4.5.3 U.A.E Inhaled Nitric Oxide Market
9.4.5.3.1 U.A.E Inhaled Nitric Oxide Market by Application
9.4.5.3.2 U.A.E Inhaled Nitric Oxide Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Inhaled Nitric Oxide Market Overview
9.5.2 South and Central America Inhaled Nitric Oxide Market Forecasts and Analysis
9.5.3 South and Central America Inhaled Nitric Oxide Market Forecasts and Analysis - By Application
9.5.4 South and Central America Inhaled Nitric Oxide Market Forecasts and Analysis - By End User
9.5.5 South and Central America Inhaled Nitric Oxide Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Inhaled Nitric Oxide Market
9.5.5.1.1 Brazil Inhaled Nitric Oxide Market by Application
9.5.5.1.2 Brazil Inhaled Nitric Oxide Market by End User
9.5.5.2 Argentina Inhaled Nitric Oxide Market
9.5.5.2.1 Argentina Inhaled Nitric Oxide Market by Application
9.5.5.2.2 Argentina Inhaled Nitric Oxide Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. INHALED NITRIC OXIDE MARKET, KEY COMPANY PROFILES
11.1. NU-MED PLUS, INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. GENOSYS, INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. PRAXAIR, INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. AIR LIQUIDE S.A.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. MALLINCKRODT PHARMACEUTICALS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MERCK KGAA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. NOVOTERIS, LLC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. IKIARA CANADA, INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. GENO LLC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. PERMA PURE LLC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Nu-Med Plus, Inc.
2. GENOSYS, Inc.
3. Praxair, Inc.
4. air Liquide S.A.
5. Mallinckrodt Pharmaceuticals
6. Merck KgaA
7. Novoteris, LLC
8. Ikiara Canada, Inc.
9. GeNO LLC
10. Perma Pure LLC
TIPRE00009274
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking